/Companies

Globeimmune

Louisville, US · Delaware corporation

Find your way into Globeimmune

Sign up to see every warm intro you have to Globeimmune

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Globeimmune team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

CJ
C. Jeffrey DekkerExecutive
TC
Timothy C. RodellExecutive
KA
Kirk A ChristoffersenExecutive

Board

CK
Charles KimBoard director
JB
Jerel BanksBoard director
PA
Paul A MieyalBoard director
DJ
Dan J MitchellBoard director
PS
Pennina SaferBoard director
AJ
Augustine J LawlorBoard director
RE
Ralph E ChristoffersenBoard director
SE
S Edward TorresBoard director
JW
J William FreytagBoard director

Reported raises · per SEC filings

Form D private placements

$10M disclosed across 3 rounds · 2013–2017

▶$2.1MraisedMar 2017 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Charles KimDirector
  • C. Jeffrey DekkerExecutive Officer
  • Jerel BanksDirector
  • Timothy C. RodellDirector
Offering amount
$2.1M
Amount sold
$2.1M
First sale
Mar 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7.5MraisedJun 2014 · 110 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • J William FreytagDirector
  • C Jeffrey DekkerExecutive Officer
  • Paul A MieyalDirector
  • Dan J MitchellDirector
  • Pennina SaferDirector
  • Augustine J LawlorDirector
  • Ralph E ChristoffersenDirector
  • Timothy C RodellExecutive Officer, Director
  • Kirk A ChristoffersenExecutive Officer
  • S Edward TorresDirector
Offering amount
$7.5M
Amount sold
$7.5M
Sales commissions
$798.6K
Placement agents
Aegis Capital Corp., Kingsbury Capital LLC
First sale
Jan 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$391.7KraisedMar 2014 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Dan J MitchellDirector
  • Ralph E ChristoffersenDirector
  • Timothy C RodellExecutive Officer, Director
  • S Edward TorresDirector
  • Augustine J LawlorDirector
  • J William FreytagDirector
  • Paul A MieyalDirector
  • Kirk A ChristoffersenExecutive Officer
  • C Jeffrey DekkerExecutive Officer
  • Pennina SaferDirector
Offering amount
$391.7K
Amount sold
$391.7K
First sale
Nov 2013
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Globeimmune raised?
Globeimmune has disclosed $10M raised across 3 rounds.
Where is Globeimmune headquartered?
Globeimmune is headquartered in Louisville, US.